Ovarian cancer survival population differences: A ''high resolution study'' comparing Philippine residents, and Filipino-Americans and Caucasians living in the US

BMC Cancer

Volumn 9, Issue , 2009, Pages 340-

  Redaniel, Maria T M ^a   Laudico, Adriano ^b,c,d   Mirasol Lumague, Maria R ^d   Gondos, Adam ^a   Uy, Gemma L ^c   Toral, Jean A ^c   Benavides, Doris ^c   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Manila Cancer Registry   (Philippines)

^c UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^d Rizal Medical Centre   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; CANCER MORPHOLOGY; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PHILIPPINES; POPULATION RESEARCH; PROGNOSIS; SURVIVAL RATE; UNITED STATES;

EID: 70449516677     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-340     Document Type: Article

References (49)

1. Parkin D, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best practice & research 2006, 20(2):207-225.
3. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0. 2004, Lyon: IARCPress.
4. Surveillance Epidemiology and End Results (SEER) Program Limited-Use Data (1973-2005) National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission. , http://www.seer.cancer.gov
5. McGuire V, Jesser CA, Whittemore AS. Survival among U.S. women with invasive epithelial ovarian cancer. Gynecologic oncology 2002, 84:399-403. 10.1006/gyno.2001.6536, 11855877.
6. Gondos A, Brenner H, Wabinga H, Parkin D. Cancer survival in Kampala, Uganda. Br J Cancer 2005, 92:1808-1812. 2362045, 15827554, 10.1038/sj.bjc.6602540.
7. Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Pulte D, Mapua C, Brenner H. Cancer survival discrepancies in developed and developing countries: comparisons between the Philippines and the United States. Br J Cancer 2009, 100(5):858-862. 10.1038/sj.bjc.6604945, 19240723.
8. Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA, Faivre J, Martinez-Garcia C, Pawlega J, Ponz de Leon M, Pottier D, Raverdy N, Williams EM, Berrino F. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000, 47(4):533-538. 1728079, 10986214, 10.1136/gut.47.4.533.
9. Sant M, Aareleid T, Artioli ME, Berrino F, Coebergh JW, Colonna M, Forman D, Hedelin G, Rachtan J, Lutz JM, Otter R, Raverdy N, Plesko II, Primic MZ, Tagliabue G. Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study. Eur J Cancer 2007, 43(3):585-592. 10.1016/j.ejca.2006.11.006, 17222545.
10. Berrino F. The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies. Ann Oncol 2003, 14(Suppl 5):v9-13. 10.1093/annonc/mdg750, 14684497.
11. Muir C, Waterhouse J, Powell J, Mack T, Whelan S, . eds Cancer Incidence in Five Continents. 1987, V. Lyon: International Agency for Research on Cancer.
12. Parkin D, Muir C, Whelan S, Gao Y, Ferlay J, Powell J, . eds Cancer Incidence in Five Continents. 1992, VI. Lyon: International Agency for Research on Cancer.
13. Parkin D, Whelan S, Ferlay J, Raymond L, Young J, . eds Cancer Incidence in Five Continents. 1997, VII. Lyon: International Agency for Research on Cancer.
14. Parkin D, Whelan S, Ferlay J, Teppo L, Thomas D, . eds Cancer Incidence in Five Continents. 2002, VIII. Lyon: International Agency for Research on Cancer.
15. Curado M, Edwards B, Shin H, Storm H, Ferlay J, Heanue M, Boyle P, . eds Cancer Incidence in Five Continents. 2007, IX. IARC Scientific Publications No. 160 Lyon: IARC.
16. International Association of Cancer Registries, International Agency for Research on Cancer Guidelines On Confidentiality For Population-based Cancer Registries, Internal Report No. 2004/03. 2004, 20-26. Lyon: IARC.
17. Stata Statistical Software: Release 6.0. 1999, College Station, Texas: Stata Corp.
18. Cutler S, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chron Dis 1958, 8:699-712. 10.1016/0021-9681(58)90126-7, 13598782.
19. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
20. Brenner H, Gefeller O. An alternative approach to monitoring cancer survival. Cancer 1996, 78:2004-2010. 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#, 8909323.
21. Brenner H, Hakulinen T. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002, 20:826-832. 10.1200/JCO.20.3.826, 11821467.
22. Brenner H, Hakulinen T. Advanced detection of time trends in long-term cancer patient survival: experience from 50 years of cancer registration in Finland. Am J Epidemiol 2002, 156:566-577. 10.1093/aje/kwf071, 12226004.
23. Brenner H, Soderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002, 31:456-462. 10.1093/ije/31.2.456, 11980816.
24. Tälback M, Stenbeck M, Rosen M. Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer 2004, 40:1361-1372. 10.1016/j.ejca.2004.02.004, 15177496.
25. Ellison L. An empirical evaluation of period survival analysis using data from the Canadian Cancer Registry. Ann Epidemiol 2006, 16:191-196. 10.1016/j.annepidem.2005.02.017, 16099673.
26. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. National Cancer Institute monograph 1961, 6:101-121.
27. Henson DE, Ries LA. The relative survival rate. Cancer 1995, 76:1687-1688. 10.1002/1097-0142(19951115)76:10<1687::AID-CNCR2820761002>3.0.CO;2-I, 8625034.
28. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. 1959, Bethesda, MD: National Cancer Institute.
29. Arias E. United States abridged life tables, 2000. National vital statistics reports; vol 51 no 3. 2002, Hyattsville, Maryland: National Center for Health Statistics.
30. Sankaranarayanan R, Black R, Parkin D. Cancer Survival in Developing Countries. 1998, Lyon: International Agency for Research on Cancer.
31. Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: model-based period analysis. Am J Epidemiol 2006, 164:689-696. 10.1093/aje/kwj243, 16840519.
32. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006, 95(Suppl 1):S161-192. 10.1016/S0020-7292(06)60033-7, 17161157.
33. Tavassoli F, Deveilee P. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. 2003, Lyon: IARC Press.
34. Brenner H, Gefeller O, Hakulinen T. Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004, 40:326-335. 10.1016/j.ejca.2003.10.013, 14746849.
35. Hensley ML. Epithelial ovarian cancer. Curr Treat Options Oncol 2002, 3(2):131-141. 10.1007/s11864-002-0059-3, 12057076.
36. Ozols RF. Update on the management of ovarian cancer. Cancer J 2002, 8(Suppl 1):S22-30.
37. Gondos A, Bray F, Hakulinen T, Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 2009, 20(3):564-573. 10.1093/annonc/mdn639, 19066327.
38. Cooper N, Quinn MJ, Rachet B, Mitry E, Coleman MP. Survival from cancer of the ovary in England and Wales up to 2001. Br J Cancer 2008, 99(Suppl 1):S70-72. 2557542, 18813266, 10.1038/sj.bjc.6604593.
39. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44(10):1345-1389. 10.1016/j.ejca.2007.12.015, 18280139.
40. Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant M. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009, 45(6):1042-1066. 10.1016/j.ejca.2008.11.029, 19124239.
41. Greene FL, Page DL, Fleming ID, Fritz AG, Balch C, Haller DG, Morrow M, . eds AJCC Cancer Staging Manual Sixth Edition. 2002, New York-Berlin-Heidelberg: Springer-Verlag.
42. Basile S, Angioli R, Manci N, Palaia I, Plotti F, Benedetti Panici P. Gynecological cancers in developing countries: the challenge of chemotherapy in low-resources setting. Int J Gynecol Cancer 2006, 16(4):1491-1497. 10.1111/j.1525-1438.2006.00619.x, 16884356.
43. Mellstedt H. Cancer initiatives in developing countries. Ann Oncol 2006, 17(Supplement 8):viii24-viii31. 10.1093/annonc/mdl984, 16801336.
44. Garcia V, Toral J, Siasu M. Malignant ovarian germ cell tumors: clinical characteristics, treatment and outcome. The experience in a tertiary government institution. Philipp J Gyn Oncol 2008, 5:54-63.
45. NSCB Metro Manila - a Gateway to the Philippines, 2005 Edition. 2006, Makati: National Statistical Coordinating Board.
46. Pisani P, Parkin D, Ngelangel C, Esteban D, Gibson L, Munson M, Reyes M, Laudico A. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006, 118:149-154. 10.1002/ijc.21343, 16049976.
47. Ikeda K, Sakai K, Yamamoto R, Hareyama H, Tsumura N, Watari H, Shimizu M, Minakami H, Sakuragi N. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer. Int J Gynecol Cancer 2003, 13:776-784. 10.1111/j.1525-1438.2003.13381.x, 14675314.
48. Ji J, Forsti A, Sundquist J, Lenner P, Hemminki K. Survival in ovarian cancer patients by histology and family history. Acta oncologica (Stockholm, Sweden) 2008, 47(6):1133-1139. 10.1080/02841860701784544, 18607880.
49. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecologic oncology 2008, 109:370-376. 10.1016/j.ygyno.2008.02.006, 18395777.